BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
PRKCA
,
T cell differentiation
,
Arthritis
,
Lymphocyte
,
Alcohol
,
Phenobarbital
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
K Homology, type 1
Summary
General Info
Curated Studies
Most Correlated Studies
Chronic myelogenous leukemia K562 cells with STAU2 shRNA knockdown
Bronchial carcinoma ChagoK1 cells with MAGOHB shRNA knockdown and MAGOH-V5 ectopic re-expression
Intestinal epithelial MODE-K cells treated with H. polygyrus derived exosomes and/or LPS
Cardiomyocytes (mature and progenitors) treated with thapsigargin, tunicamycin or halofuginone
Th17 cell gene expression response to salt (NaCl)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for K Homology, type 1
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologo…
A Blood Collection Study to Assess the Immunogenicity of Nationally Authorized Homologous COVID-19 B…
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologo…
A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-N…
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ